Home
Fenwick
Ewa M. Davison
Ewa M. Davison
Fenwick
A Cautiously Optimistic Diagnosis For Patent Eligibility
16 May 2018 | United States
Litigation Alert: Supreme Court Extends Petrella Rule Barring Laches To Patent Context
07 Apr 2017 | United States
Biosimilars: Solicitor General Recommends Granting Certiorari In Amgen v. Sandoz
29 Dec 2016 | United States
Will The Supreme Court Review Whether FDA-Mandated Bioequivalence Testing To Maintain Approval Falls Within The § 271(e)(1) Safe Harbor?
19 Aug 2016 | United States
Federal Circuit: A Biosimilar Applicant Must Provide Notice Of Intent To Market A Biosimilar Product, No Exceptions
25 Jul 2016 | United States
Litigation Alert: No Exception To Statutory Requirement That A Biosimilar Applicant Provide Notice Of Intent To Market Its Product
20 Jul 2016 | United States
Litigation Alert: Supreme Court Leaves Intact PTAB Authority To Institute And Regulate Inter Partes Review Proceedings
01 Jul 2016 | United States
Biosimilars: Supreme Court Calls For Solicitor General's Views In Amgen V. Sandoz
30 Jun 2016 | United States
Riddle Me This: The Federal Circuit Provides A Measure Of Clarity To The Enigmatic Biosimilar Approval Pathway
12 Aug 2015 | United States
Murky Waters: Post-Approval Regulatory Activities And The § 271(e)(1) Safe Harbor
10 Apr 2013 | United States
IP Litigation Alert: PTO Publishes Final Rules For Contested Patent Cases
20 Aug 2012 | United States
Supreme Court Allows Generic Manufacturers To Challenge Overbroad Use Codes
09 May 2012 | United States
Contact Details
California
California
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.